{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T01:50:38Z","timestamp":1764035438593,"version":"3.45.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:00:00Z","timestamp":1795132800000},"content-version":"am","delay-in-days":445,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017618","name":"National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jacl.2025.06.003","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T20:06:34Z","timestamp":1750709194000},"page":"1395-1407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipoprotein profiles across a spectrum of insulin signaling"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5546-6812","authenticated-orcid":false,"given":"Michael","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Shamburek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0885-250X","authenticated-orcid":false,"given":"Maureen","family":"Sampson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent S.","family":"Abel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5498-0452","authenticated-orcid":false,"given":"Marissa","family":"Lightbourne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2589-7382","authenticated-orcid":false,"given":"Rebecca J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jacl.2025.06.003_bib0001","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1172\/JCI10762","article-title":"Insulin resistance and cardiovascular disease","volume":"106","author":"Ginsberg","year":"2000","journal-title":"J Clin Investig"},{"issue":"5","key":"10.1016\/j.jacl.2025.06.003_bib0002","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/er.2007-0006","article-title":"Cardiovascular actions of insulin","volume":"28","author":"Muniyappa","year":"2007","journal-title":"Endocrine Rev"},{"issue":"8","key":"10.1016\/j.jacl.2025.06.003_bib0003","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/ATVBAHA.111.241885","article-title":"Insulin resistance and coronary heart disease in nondiabetic individuals","volume":"32","author":"Reaven","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2025.06.003_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1161521","article-title":"Obesity and type 2 diabetes mellitus: connections in epidemiology, pathogenesis, and treatments","volume":"14","author":"Ruze","year":"2023","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.003_bib0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metabolism"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.003_bib0006","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2007.11.013","article-title":"Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis","volume":"7","author":"Biddinger","year":"2008","journal-title":"Cell Metabolism"},{"issue":"5","key":"10.1016\/j.jacl.2025.06.003_bib0007","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4158\/EP12139.RA","article-title":"Syndromic insulin resistance: models for the therapeutic basis of the metabolic syndrome and other targets of insulin resistance","volume":"18","author":"Gorden","year":"2012","journal-title":"Endocrine Pract"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.003_bib0008","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200203000-00001","article-title":"Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective","volume":"81","author":"Arioglu","year":"2002","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.003_bib0009","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MED.0000000000000263","article-title":"Type B insulin resistance syndrome","volume":"23","author":"Willard","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obesity"},{"issue":"11","key":"10.1016\/j.jacl.2025.06.003_bib0010","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.2337\/dc18-0884","article-title":"Combined immunosuppressive therapy induces remission in patients with severe type B insulin resistance: a prospective cohort study","volume":"41","author":"Klubo-Gwiezdzinska","year":"2018","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.jacl.2025.06.003_bib0011","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.003_bib0012","first-page":"315","article-title":"Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis","volume":"119","author":"Semple","year":"2009","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.003_bib0013","doi-asserted-by":"crossref","first-page":"491","DOI":"10.14336\/AD.2021.0929","article-title":"The functional role of lipoproteins in atherosclerosis: novel directions for diagnosis and targeting therapy","volume":"13","author":"Lu","year":"2022","journal-title":"Aging Dis"},{"issue":"11-12","key":"10.1016\/j.jacl.2025.06.003_bib0014","first-page":"544","volume":"26","author":"Otvos","year":"2002","journal-title":"LaboratoriumsMedizin"},{"issue":"7","key":"10.1016\/j.jacl.2025.06.003_bib0015","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/CIRCULATIONAHA.108.816181","article-title":"Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women","volume":"119","author":"Mora","year":"2009","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.003_bib0016","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"issue":"11","key":"10.1016\/j.jacl.2025.06.003_bib0017","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.2337\/dc18-0884","article-title":"Combined immunosuppressive therapy induces remission in patients with severe type B insulin resistance: a prospective cohort study","volume":"41","author":"Klubo-Gwiezdzinska","year":"2018","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.jacl.2025.06.003_bib0018","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1001\/jamacardio.2020.0013","article-title":"A new equation for calculation of low-density lipoprotein cholesterol in patients with normolipidemia and\/or hypertriglyceridemia","volume":"5","author":"Sampson","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"11","key":"10.1016\/j.jacl.2025.06.003_bib0019","article-title":"Insulin at 100\u2005years\u2014is rebalancing its action key to fighting obesity-related disease?","volume":"14","author":"Brierley","year":"2021","journal-title":"Dis Models Mechan"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.003_bib0020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/diabetes.52.2.453","article-title":"Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance","volume":"52","author":"Garvey","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.jacl.2025.06.003_bib0021","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2023.16","article-title":"The role of triglyceride-rich lipoproteins and their remnants in atherosclerotic cardiovascular disease","volume":"18","author":"Gabani","year":"2023","journal-title":"Eur Cardiol"},{"issue":"8","key":"10.1016\/j.jacl.2025.06.003_bib0022","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1210\/js.2019-00103","article-title":"Advanced lipoprotein analysis shows atherogenic lipid profile that improves after metreleptin in patients with lipodystrophy","volume":"3","author":"Kinzer","year":"2019","journal-title":"J Endocrine Soc"},{"issue":"7","key":"10.1016\/j.jacl.2025.06.003_bib0023","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1172\/JCI135431","article-title":"Free fatty acid processing diverges in human pathologic insulin resistance conditions","volume":"130","author":"Sekizkardes","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.jacl.2025.06.003_bib0024","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fphar.2015.00218","article-title":"HDL particle number and size as predictors of cardiovascular disease","volume":"6","author":"Kontush","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jacl.2025.06.003_bib0025","first-page":"1","article-title":"High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease","volume":"7","author":"Kosmas","year":"2018","journal-title":"Drugs Context"},{"issue":"10","key":"10.1016\/j.jacl.2025.06.003_bib0026","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.003_bib0027","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1567-5688(02)00041-7","article-title":"Hugh Sinclair Lecture: the regulation and remodelling of HDL by plasma factors","volume":"3","author":"Barter","year":"2002","journal-title":"Atheroscler Suppl"},{"issue":"4","key":"10.1016\/j.jacl.2025.06.003_bib0028","first-page":"66","article-title":"Lecithin-cholesterol acyltransferase (LCAT) activity is lower in patients with type 2 diabetes in the presence of metabolic syndrome","volume":"3","author":"Nakhjavani","year":"2020","journal-title":"Bioactive Compounds Health Dis"},{"issue":"6","key":"10.1016\/j.jacl.2025.06.003_bib0029","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1464-5491.1991.tb01652.x","article-title":"The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes","volume":"8","author":"Baynes","year":"1991","journal-title":"Diabetic Med"},{"key":"10.1016\/j.jacl.2025.06.003_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1273042","article-title":"Small dense low-density lipoprotein as biomarker for atherosclerotic diseases","volume":"2017","author":"Ivanova","year":"2017","journal-title":"Oxid Med Cell Longevity"},{"key":"10.1016\/j.jacl.2025.06.003_bib0031","series-title":"StatPearls","article-title":"Physiology, complement cascade","author":"Bardhan","year":"2025"},{"key":"10.1016\/j.jacl.2025.06.003_bib0032","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2147\/VHRM.S17015","article-title":"Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus","volume":"7","author":"Olusi","year":"2011","journal-title":"Vasc Health Risk Management"},{"issue":"2","key":"10.1016\/j.jacl.2025.06.003_bib0033","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.atherosclerosis.2009.07.015","article-title":"Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-na\u00efve patients with early rheumatoid arthritis","volume":"207","author":"Rizzo","year":"2009","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.jacl.2025.06.003_bib0034","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.numecd.2018.06.022","article-title":"Small dense LDL cholesterol in human subjects with different chronic inflammatory diseases","volume":"28","author":"Schulte","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis"},{"year":"2000","series-title":"The Effect of Inflammation and Infection on Lipids and Lipoproteins","author":"Feingold","key":"10.1016\/j.jacl.2025.06.003_bib0035"},{"issue":"7","key":"10.1016\/j.jacl.2025.06.003_bib0036","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","article-title":"Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host","volume":"45","author":"Khovidhunkit","year":"2004","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1016\/j.jacl.2025.06.003_bib0037","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1172\/JCI95476","article-title":"Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy","volume":"128","author":"Brown","year":"2018","journal-title":"J Clin Investig"},{"issue":"3","key":"10.1016\/j.jacl.2025.06.003_bib0038","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00247.2020","article-title":"Endothelial dysfunction due to selective insulin resistance in vascular endothelium: insights from mechanistic modeling","volume":"319","author":"Muniyappa","year":"2020","journal-title":"Am J Physiol. Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jacl.2025.06.003_bib0039","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.2337\/dc12-0638","article-title":"PAI-1 and diabetes: a journey from the bench to the bedside","volume":"35","author":"Schneider","year":"2012","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.jacl.2025.06.003_bib41","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.2337\/diabetes.51.12.3391","article-title":"Interleukin-6 induces cellular insulin resistance in hepatocytes","volume":"51","author":"Senn","year":"2002","journal-title":"Diabetes"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425003204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425003204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T01:46:07Z","timestamp":1764035167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425003204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1933287425003204"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.06.003","relation":{},"ISSN":["1933-2874"],"issn-type":[{"type":"print","value":"1933-2874"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein profiles across a spectrum of insulin signaling","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}